Tackling ALK-positive LBCL
Blood
.
2022 Oct 20;140(16):1751-1752.
doi: 10.1182/blood.2022017742.
Authors
Fabian Frontzek
1
,
Georg Lenz
1
Affiliation
1
University Hospital Münster.
PMID:
36264594
DOI:
10.1182/blood.2022017742
No abstract available
Publication types
Comment
MeSH terms
Anaplastic Lymphoma Kinase / genetics
Humans
Lymphoma, Large B-Cell, Diffuse*
Receptor Protein-Tyrosine Kinases* / genetics
Substances
Anaplastic Lymphoma Kinase
Receptor Protein-Tyrosine Kinases